AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
For Tessenderlo Group's Other Businesses (Organic Chlorine Derivatives, Pharmaceutical Intermediates and Compounds operating segments), revenue reached EUR 79.6 M in 4Q 2010 or 13.3% above 4Q 2009. Organic Chlorine Derivatives generated nearly all of the increase, Compounds also rose and Pharmaceutical Intermediates was lower. REBITDA was slightly positive, at EUR 0.5 M (-3.8% year on year) as Organic Chlorine Derivatives moved from a …